# ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer

Page: https://stenobird.com/podcast/lung-cancer-considered-246259/asco-2026-highlights-part-2-emerging-immunotherapy-strategies-in-lung-cancer
Text version: https://stenobird.com/podcast/lung-cancer-considered-246259/asco-2026-highlights-part-2-emerging-immunotherapy-strategies-in-lung-cancer.md
Podcast: [Lung Cancer Considered](https://stenobird.com/podcast/lung-cancer-considered-246259)
Published: 2026-06-09T13:00:43+00:00
Episode link: https://soundcloud.com/lungcancerconsidered/asco-2026-highlights-part-2
Audio file: https://feeds.soundcloud.com/stream/2335068584-lungcancerconsidered-asco-2026-highlights-part-2.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/asco-2026-highlights-part-2-emerging-immunotherapy-strategies-in-lung-cancer
Duration seconds: 2418

## Resource

In Part 2 of the ASCO 2026 Highlights series, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Julie Brahmer and Dr. Solange Peters to discuss some of the most notable immunotherapy advances presented at the 2026 ASCO Annual Meeting. The conversation explores emerging data for PD-1/VEGF and PD-L1/VEGF bispecific antibodies, the growing role of antibody-drug conjugates in combination with immunotherapy, and promising new strategies targeting KRAS-mutant lung cancers, highlighting how these approaches may reshape the future treatment landscape. Guests: Julie R. Brahmer, MD, MSc, FASCO, FAIO The Marilyn Meyerhoff Professor of Thoracic Oncology Co-Leader, Cancer Immunology Research Program Co-Director, Upper Aerodigestive Cancers Program Director, Johns Hopkins Kimmel Cancer Center, Bayview Campus Professor Solange Peters, MD, PhD Chair of Medical Oncology Director of Oncology Department - CHUV Lausanne University Hospital

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/asco-2026-highlights-part-2-emerging-immunotherapy-strategies-in-lung-cancer/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/lung-cancer-considered-246259/asco-2026-highlights-part-2-emerging-immunotherapy-strategies-in-lung-cancer.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.